Ustekinumab use in lactation: drug pharmacokinetics and normal development in exposed infants
2025-12-27
SCID: 54.1/zsbgtqju
Abstract (AI)
Lay Summary Ustekinumab was excreted into breast milk at very low levels after both subcutaneous and intravenous administration. Infant serum levels declined despite ongoing breastfeeding, and long-term follow-up showed normal development and no adverse events, supporting continued breastfeeding during ustekinumab treatment.
Key Findings
Research Object
Research Subject
Publication Details
Publication Date
2025-12-27
Journal
Publisher
ISSN
Access Type
Author Information
Download PDF